University of Oxford, Queen's University Belfast

Academic Institute

Declan Bradley

E064

The aim of this study is to assess the safety, effectiveness and uptake of the currently licenced COVID-19 vaccines (Pfizer-BioNTech, Oxford-AstraZeneca and Moderna) in the UK. To do this, we will use anonymised individual level data routinely collected at primary, secondary, linked with mortality, laboratory and vaccination data across the UK. Unique national datasets will be developed and hosted within a Trusted Research Environment (TRE) in each UK nation with standardised individual-level analyses run across datasets. Pooled estimates across the UK national will also be provided. Specifically, our objectives are to: a) assess any vaccine related adverse events; b) assess vaccine effectiveness (VE) including household transmission; and c) measure variation in vaccine uptake

The findings from this study are anticipated to provide important public health information on uptake characteristics and the safety and effectiveness of the vaccination programme in the NI population.

18/03/2021

Anonymous

Not applicable

Not applicable

Not applicable

Recurring

TRE